Using MRD status as a metric of CAR-T efficacy in patients with multiple myeloma

Using MRD status as a metric of CAR-T efficacy in patients with multiple myeloma

IMWG Conference Series: Reporting from ASH 2022Подробнее

IMWG Conference Series: Reporting from ASH 2022

2019 Multiple Myeloma Symposium | Novel and Next Generation TherapyПодробнее

2019 Multiple Myeloma Symposium | Novel and Next Generation Therapy

New Directions in Treating Multiple Myeloma in the Era of Novel AgentsПодробнее

New Directions in Treating Multiple Myeloma in the Era of Novel Agents

Myeloma Updates 2018: Best of ASCO/EHA/IMWGПодробнее

Myeloma Updates 2018: Best of ASCO/EHA/IMWG

How is multiple myeloma diagnosed and how do risk factors affect treatment? By Dr. Nikhil MunshiПодробнее

How is multiple myeloma diagnosed and how do risk factors affect treatment? By Dr. Nikhil Munshi

Multiple Myeloma: A Pathway to Better OutcomesПодробнее

Multiple Myeloma: A Pathway to Better Outcomes